Pacific Shuanglin Bio pharmacy Co Ltd (000403) — Cash Flow Reinvestment Rate
Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Cash Flow Reinvestment Rate of 1.03x as of September 2025, reinvesting CN¥72.17 Million (capex CN¥72.17 Million ) from operating cash flow of CN¥70.28 Million. Check earnings quality score of Pacific Shuanglin Bio pharmacy Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Pacific Shuanglin Bio pharmacy Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Pacific Shuanglin Bio pharmacy Co Ltd across 21 annual periods. Explore Pacific Shuanglin Bio pharmacy Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Pacific Shuanglin Bio pharmacy Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Pacific Shuanglin Bio pharmacy Co Ltd. For live market cap and broader valuation context, see market cap of Pacific Shuanglin Bio pharmacy Co Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 2.11x | CN¥679.47 Million | CN¥321.79 Million | CN¥520.71 Million | ▲ +115.1% |
| 2023 | 0.98x | CN¥666.48 Million | CN¥679.01 Million | CN¥377.27 Million | ▼ -18.1% |
| 2022 | 1.20x | CN¥628.64 Million | CN¥524.22 Million | CN¥378.64 Million | ▲ +1.5% |
| 2021 | 1.18x | CN¥482.46 Million | CN¥408.22 Million | CN¥326.16 Million | ▲ +17.2% |
| 2020 | 1.01x | CN¥196.48 Million | CN¥194.84 Million | CN¥40.18 Million | ▼ -2.5% |
| 2019 | 1.03x | CN¥197.41 Million | CN¥190.84 Million | CN¥41.11 Million | ▲ +201.5% |
| 2018 | 0.34x | CN¥40.02 Million | CN¥116.63 Million | CN¥35.02 Million | ▼ -91.4% |
| 2016 | 3.98x | CN¥248.83 Million | CN¥62.49 Million | CN¥98.03 Million | ▲ +334.8% |
| 2015 | 0.92x | CN¥64.39 Million | CN¥70.31 Million | CN¥59.39 Million | ▼ -0.7% |
| 2014 | 0.92x | CN¥71.05 Million | CN¥77.04 Million | CN¥71.05 Million | ▼ -48.5% |
| 2013 | 1.79x | CN¥162.99 Million | CN¥91.01 Million | CN¥162.99 Million | ▲ +22.4% |
| 2012 | 1.46x | CN¥180.28 Million | CN¥123.24 Million | CN¥180.28 Million | ▲ +158.7% |
| 2011 | 0.57x | CN¥73.58 Million | CN¥130.14 Million | CN¥73.58 Million | ▼ -84.7% |
| 2010 | 3.69x | CN¥36.46 Million | CN¥9.88 Million | CN¥36.46 Million | ▲ +487.4% |
| 2009 | 0.63x | CN¥70.29 Million | CN¥111.86 Million | CN¥70.29 Million | ▲ +8.0% |
| 2008 | 0.58x | CN¥43.59 Million | CN¥74.90 Million | CN¥43.59 Million | ▲ +776.6% |
| 2007 | 0.07x | CN¥6.31 Million | CN¥95.03 Million | CN¥6.31 Million | ▼ -53.2% |
| 2005 | 0.14x | CN¥6.95 Million | CN¥49.06 Million | CN¥6.95 Million | ▼ -74.7% |
| 2002 | 0.56x | CN¥89.09 Million | CN¥159.18 Million | CN¥89.09 Million | ▼ -29.2% |
| 2001 | 0.79x | CN¥87.96 Million | CN¥111.28 Million | CN¥87.96 Million | ▼ -61.8% |
| 2000 | 2.07x | CN¥56.62 Million | CN¥27.36 Million | CN¥56.62 Million | — |